官方服务：
资源简介：
Whole Genome Sequencing of the SARS-CoV-2 in Myanmar
应用场景：
创建时间：
2020-12-27
相关数据集
Raw SARS-CoV-2 sequencing data available at the time of writing (Feb 20, 2020).
*Indicates that data may not be reliable (for example, the link between SRR10903402 and [1] is inferred: neither the SRA record nor the manuscript establishes this relationship). On February 21, 2020
NIAID Data Ecosystem40
SARS-CoV-2 sequencing data collected from the New York City metropolitan area, vaccine breakthrough cases, May to August 2021 (Raw sequence reads)
The Delta variant has become the predominant SARS-CoV-2 variant in the United States and worldwide. We describe clinical, demographic, and genomic features of SARS-CoV-2 breakthrough infections betwee
NIAID Data Ecosystem30
SARS-CoV-2 WGS: IEH Laboratories and Consulting Group
Whole-genome sequencing of SARS-CoV-2 as part of surveillance effort.
NIAID Data Ecosystem20
NR-55654: Isolate hCoV-19/Peru/un-CDC-2-4069945/2021 (Lineage C.37; Lambda Variant).
NR-55654: Isolate hCoV-19/Peru/un-CDC-2-4069945/2021 (Lineage C.37; Lambda Variant).
NIAID Data Ecosystem30
Guidelines for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples
SARS-CoV-2 genotyping has been instrumental to monitor virus evolution and transmission during the pandemic. The reliability of information, which can be extracted from the genotyping efforts, depends
NIAID Data Ecosystem20
